Edition:
India

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

161.70USD
23 Feb 2018
Change (% chg)

$2.74 (+1.72%)
Prev Close
$158.96
Open
$159.64
Day's High
$161.75
Day's Low
$159.13
Volume
274,516
Avg. Vol
372,064
52-wk High
$170.00
52-wk Low
$127.21

Latest Key Developments (Source: Significant Developments)

3D Systems Corp, Stryker Announce Exclusive Distribution Partnership
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - 3D Systems Corp ::3D SYSTEMS - CO, STRYKER ANNOUNCED EXCLUSIVE DISTRIBUTION PARTNERSHIP FOR VSP & ANATOMICAL MODELS FOR CRANIOMAXILLOFACIAL SPECIALTY.3D SYSTEMS - AGREEMENT BETWEEN CO, STRYKER IS SPECIFIC TO U.S., CANADA, EUROPE, AUSTRALIA.  Full Article

BRIEF-Vexim 2017 Sales Up 17 Pct To 21.6 Million Euros
Friday, 12 Jan 2018 

Refiles to add missing 4th bullet.:VEXIM: +17% GROWTH IN SALES IN 2017 UP TO €21.6 MILLION.‍2017 SALES RESULTS PERFORMS BELOW EXPECTATIONS OF MANAGEMENT WHICH ANTICIPATED AN ANNUAL GROWTH OF +30%​.‍PROFITABILITY TARGET FOR 2017 WILL NOT BE ACHIEVED.FY ‍FINANCIAL RESULT WILL BE ADVERSELY AFFECTED BY EUR 5 MLN EXCEPTIONAL EXPENSES, PART OF OPERATION WITH STRYKER​.  Full Article

Stryker Expects 2017 Adj Net Earnings Per Diluted Share To Be Toward High End Of Previous Range Of $6.45-$6.50​
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Stryker Corp ::STRYKER - EXPECT 2017 ADJUSTED NET EARNINGS PER DILUTED SHARE TO BE TOWARD HIGH END OF PREVIOUSLY ANNOUNCED RANGE OF $6.45 TO $6.50​.- EXPECT 2017 ADJUSTED NET EARNINGS PER DILUTED SHARE TO BE TOWARD HIGH END OF OUR PREVIOUSLY ANNOUNCED RANGE OF $6.45 TO $6.50​.- WITH RESPECT TO U.S. TAX REFORM, ANTICIPATE A MODEST HEADWIND FOR 2018.STRYKER - ‍FOREIGN CURRENCY EXCHANGE IMPACT ON NET SALES IN Q4 WAS POSITIVE OF ABOUT 1.2 PERCENT AND NOMINAL IN FULL YEAR​.REG-STRYKER PROVIDES 2017 PRELIMINARY NET SALES RESULTS.Q4 SALES $3.5 BILLION VERSUS I/B/E/S VIEW $3.39 BILLION.STRYKER SAYS PRELIMINARY ORTHOPAEDICS NET SALES OF $1.3 BILLION AS REPORTED IN Q4.- ‍PRELIMINARY DOMESTIC NET SALES OF $2.5 BILLION AND $9.1 BILLION INCREASED 9.3% AND 10.1% AS REPORTED IN Q4 AND FULL YEAR​.- ‍PRELIMINARY INTERNATIONAL NET SALES OF $1.0 BILLION AND $3.4 BILLION INCREASED 11.7% AND 9.4% AS REPORTED IN Q4 AND FULL YEAR​.Q4 REVENUE VIEW $3.39 BILLION -- THOMSON REUTERS I/B/E/S.FY2017 EARNINGS PER SHARE VIEW $6.47 -- THOMSON REUTERS I/B/E/S.  Full Article

Entellus Medical Says Deal May Require Co To Pay Stryker A Termination Fee Of $20.5 Mln
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL SAYS DEAL PROVIDES CO MAY BE REQUIRED TO PAY STRYKER TERMINATION FEE OF $20.5 MILLION UNDER CERTAIN CIRCUMSTANCES - SEC FILING.  Full Article

Stryker to buy Entellus Medical for $24.00/share in cash
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH.DEAL FOR EQUITY VALUE OF ABOUT $662 MILLION.‍ENTELLUS BOARD OF DIRECTORS UNANIMOUSLY APPROVED ENTERING INTO AGREEMENT​.  Full Article

Stryker declares $0.47 per share quarterly dividend
Thursday, 7 Dec 2017 

Dec 6 (Reuters) - Stryker Corp ::STRYKER INCREASES DIVIDEND 11%, DECLARING A $0.47 PER SHARE QUARTERLY DIVIDEND.  Full Article

Stryker receives U.S. FDA HDE approval for the Neuroform Atlas stent system to treat wide neck aneurysms
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Stryker Corp :Stryker receives U.S. FDA HDE approval for the Neuroform Atlas™ stent system to treat wide neck aneurysms.Stryker Corp - ‍Approval allows company to begin U.S. commercialization efforts for Neuroform Atlas stent system​ immediately.  Full Article

Stryker Corp reports Q3 earnings per share $1.14
Friday, 27 Oct 2017 

Oct 26 (Reuters) - Stryker Corp :Stryker reports third quarter 2017 results.Sees Q4 adjusted earnings per share $1.92 to $1.97.Q3 adjusted earnings per share $1.52.Q3 earnings per share $1.14.Q3 sales $3.0 billion versus I/B/E/S view $2.97 billion.Q3 earnings per share view $1.50 -- Thomson Reuters I/B/E/S.Stryker Corp - ‍expect 2017 organic net sales growth to be in range of 6.5 pct to 7.0 pct​.Stryker Corp - ‍expect adjusted 2017 net earnings per diluted share to be in range of $6.45 to $6.50​.Fy2017 earnings per share view $6.44, revenue view $12.29 billion -- Thomson Reuters I/B/E/S.  Full Article

Stryker to acquire Vexim
Wednesday, 25 Oct 2017 

Oct 24 (Reuters) - Stryker Corp :Stryker to acquire Vexim.Stryker Corp - ‍Stryker paid EUR 20.00 per share and EUR 3.91 per BSAAR warrant for deal​.Stryker Corp says ‍transaction is expected to be neutral to Stryker's 2017 adjusted net earnings per diluted share​.Stryker - ‍indirectly acquired securities held by some Vexim shareholders, managers, representing 50.7 pct of share capital, 50.3 pct of voting rights of co​.Stryker - deal ‍price represents equity value of Vexim on fully diluted basis of about EUR 183 million, corresponding to enterprise value of about EUR 162 million​.  Full Article

NOVADAQ enters into agreement to be acquired by Stryker
Monday, 19 Jun 2017 

June 19 (Reuters) - Novadaq Technologies Inc :Novadaq enters into agreement to be acquired by stryker corporation.Novadaq technologies inc - deal for total equity value of approximately us$701 million.Novadaq technologies says stryker has agreed to acquire all of issued and outstanding shares of novadaq for us$11.75 per share in cash.Novadaq technologies says transaction will be carried out by way of court approved plan of arrangement under canada business corporations act.Novadaq technologies inc - arrangement agreement provides for payment of termination fee of $21.0 million by novadaq to stryker in certain circumstances.  Full Article

BRIEF-Stryker Says Holds 95 Pct In Vexim; Intends To File Public Buy-Out Offer

* STRYKER CROSSES THE 95% THRESHOLDS IN VEXIM AND ANNOUNCES ITS INTENTION TO FILE A PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT FOR THE OUTSTANDING SHARES OF VEXIM